Europe is reeling from the shock news that biotech giant AstraZeneca will not be delivering anything like the number of vaccines it promised. The company informed European Union officials that they will only be supplying 31 million doses to 27 E.U. countries, rather than the 80 million they had promised would arrive by the end of March. Italian
Unable to secure a profit in immunizing poorer nations, Western multinationals, including Oxford’s private partner AstraZeneca, have prioritized those who can pay the most.